alpha receptor antagonist
2024HS197
Phase 1 small_molecule active
Quick answer
alpha receptor antagonist for Prostatic Hypertrophy, Benign is a Phase 1 program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- Prostatic Hypertrophy, Benign
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active